RetaMaps

Maniya Health: Primary & Urgent Care. Reimagined.

Maniya Health: Primary & Urgent Care. Reimagined. · 1078 White Horse Avenue · Hamilton Township, NJ 08610

4.9· 2,067 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Maniya Health is a primary and urgent care practice in Hamilton Township, New Jersey, with additional offices in Robbinsville and Hopewell, and telehealth is available. Its website references serving patients since 2001 and lists physicians including Mariam Maniya, MD, Omar Maniya, MD, and Jigar Shah, DO. For weight management, the site says it offers medical weight loss with prescription medications, naming Wegovy and Mounjaro among others. Google shows a 4.9-star rating across 2,067 reviews dating back to 2021, with 21 in the past year; reviewers most often mention a caring approach and the physicians' knowledge.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsYes
Cash pay acceptedYes
Accepts insurance — per practice websiteNot listed
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.9
Google rating · 2,067 reviews
21
reviews in the past year (avg ★ 5.0)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-29. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.9 across 2,067 Google reviews. Of the 35 reviews we analyzed, 35 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Feeling listened to11 reviews
  • Knowledgeable, professional providers10 reviews
  • Friendly, helpful staff9 reviews
  • Short waits, on-time visits2 reviews

Common complaints

No negative reviews among those we analyzed.

5★
34
4★
1
3★
0
2★
0
1★
0

Most recent Google reviews

Mark S.★★★★★2026-09-26

Kunti is great to have as a primary doctor. Knowledgeable, great bedside manner and very proactive on health issues.

Invictus P.★★★★★2026-09-20

Brought my mom to the clinic to see Dr. Singh. First of all the staff in the reception and the MAs were very helpful and professional towards my mother and myself, and Dr. Singh did an excellent job in answering all the questions that my mother had about her diabetes and blood pressure issues and explained her very clearly about the medicine dose and the reason for choosing those medicines. I highly recommend this clinic and the one in Robbinsville.

Tabatha★★★★★2026-09-19

The whole STAFF is always polite and does everything they can to accommodate your needs, especially if you leave a message (they always call back at a reasonable time). The doctor's actually LISTEN to you and don't blow off your concerns like some other doctors I've seen in the past. I've been seeing Kunti Patel for almost 8 years now and I absolutely love her. Would 100% recommend her! I also had the privilege to have seen Lauren multiple times over the last year on emergency visits and even walk-ins (yes they have walk-in) and she is incredible. I always leave feeling better knowing I have a huge team helping me get through my hectic chronic medical conditions. Also a convenient plus, you can get your blood work and x-rays done in the same building (down the hall). And the phlebotomist actually knows what they're doing (I'm a hard stick 🙄😂). You might have to wait a little longer then your scheduled appointment time, but thats only because like I said, they actual listen to your concerns and they give you answers to those concerns. Just talk to the staff at the front desk if its "a big deal" and they will try and help, just be nice about it 💕

Mubide D.★★★★★2026-09-17

I went in for a general checkup and to establish care with a primary care physician, and I had a great experience from start to finish! From the moment I walked in, everything was smooth, quick, and well organized. Medical assistant Yamina was so kind, helpful, and welcoming. I then saw Dr. Leslie Presbot, who patiently answered all of my questions and never made me feel rushed. I was also able to get my blood work done right there in the office on the same day, which was so convenient. The whole visit took about 30 minutes. Overall, I had a wonderful experience and really appreciated how efficient, professional, and caring everyone was!

Magda C.★★★★★2026-09-17

Excelente trato humano del Doctor Maniya .

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Hamilton Township

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs